Literature DB >> 10730922

Secretion and tissue content of eosinophil cationic protein in Crohn's disease.

S Winterkamp1, M Raithel, E G Hahn.   

Abstract

To define further the role of eosinophils in the pathogenesis of Crohn's disease, the secretion rate and tissue content of eosinophilic cationic protein (ECP) were measured in colorectal samples. Mucosal biopsies were obtained from 22 controls and 20 patients with Crohn's disease during colonoscopy. After measurement of the initial basal ECP, release samples were incubated using a mucosa oxygenation system. Spontaneous and antiimmunoglobulin E (anti-IgE)-induced secretions of ECP were measured at different time points. For detection of the remaining tissue, ECP amount samples were mechanically homogenized after the incubation period. ECP measurement was performed by radioimmunoassay. Spontaneous ECP secretion rates during the incubation period were similar in all patient groups, whereas the initial basal ECP secretion was significantly increased in tissue affected by Crohn's disease. After stimulation with anti-IgE, ECP secretion was increased two-fold in controls and three-fold in patients with Crohn's disease. In tissue affected by Crohn's disease, ECP levels were found to be significantly increased in most segments of the lower gastrointestinal tract with the highest ECP concentrations in affected mucosa. This functional study demonstrates an enhanced immunologically mediated ECP secretion and an accumulation of ECP in the intestinal mucosa of Crohn's disease, indicating a local upregulation of eosinophils.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10730922     DOI: 10.1097/00004836-200003000-00009

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  12 in total

1.  Mucosal pathophysiology and inflammatory changes in the late phase of the intestinal allergic reaction in the rat.

Authors:  P C Yang; M C Berin; L Yu; M H Perdue
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

2.  Nanoparticulate Drug Delivery Systems Targeting Inflammation for Treatment of Inflammatory Bowel Disease.

Authors:  Sufeng Zhang; Robert Langer; Giovanni Traverso
Journal:  Nano Today       Date:  2017-10-09       Impact factor: 20.722

3.  Inhibition of the interactions between eosinophil cationic protein and airway epithelial cells by traditional Chinese herbs.

Authors:  Hao-Teng Chang; Louis J Tseng; Ta-Jen Hung; Blacky T Kao; Wei-Yong Lin; Tan-chi Fan; Margaret Dah-Tsyr Chang; Tun-Wen Pai
Journal:  BMC Syst Biol       Date:  2010-09-13

4.  Eosinophil infiltration, gastric juice and serum eosinophil cationic protein levels in Helicobacter pylori-associated chronic gastritis and gastric ulcer.

Authors:  Selim A Aydemir; Isak Ozel Tekin; Gamze Numanoglu; Ali Borazan; Yucel Ustundag
Journal:  Mediators Inflamm       Date:  2004-12       Impact factor: 4.711

5.  Investigation of potential early Histologic markers of pediatric inflammatory bowel disease.

Authors:  Julie A Bass; Craig A Friesen; Amanda D Deacy; Nancy A Neilan; Julia M Bracken; Valentina Shakhnovich; Vivekanand Singh
Journal:  BMC Gastroenterol       Date:  2015-10-13       Impact factor: 3.067

6.  Clinical value of serum eosinophilic cationic protein assessment in children with inflammatory bowel disease.

Authors:  Andrzej Wędrychowicz; Przemysław Tomasik; Stanisław Pieczarkowski; Kinga Kowalska-Duplaga; Zofia Grzenda-Adamek; Krzysztof Fyderek
Journal:  Arch Med Sci       Date:  2013-04-09       Impact factor: 3.318

7.  Chemoattraction of macrophages by secretory molecules derived from cells expressing the signal peptide of eosinophil cationic protein.

Authors:  Yu-Shu Liu; Pei-Wen Tsai; Yong Wang; Tan-Chi Fan; Chia-Hung Hsieh; Margaret Dah-Tsyr Chang; Tun-Wen Pai; Chien-Fu Huang; Chung-Yu Lan; Hao-Teng Chang
Journal:  BMC Syst Biol       Date:  2012-08-20

8.  Eosinophil-derived neurotoxin is elevated in patients with amyotrophic lateral sclerosis.

Authors:  Guan-Ting Liu; Chi-Shin Hwang; Chia-Hung Hsieh; Chih-Hao Lu; Sunny Li-Yun Chang; Jin-Ching Lee; Chien-Fu Huang; Hao-Teng Chang
Journal:  Mediators Inflamm       Date:  2013-02-20       Impact factor: 4.711

9.  Activated eosinophils in association with enteric nerves in inflammatory bowel disease.

Authors:  Claire M Smyth; Nadim Akasheh; Sara Woods; Elaine Kay; Ross K Morgan; Margaret A Thornton; Anthony O'Grady; Robert Cummins; Orla Sheils; Peter Smyth; Gerald J Gleich; Frank M Murray; Richard W Costello
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

10.  Increased Colonic Epithelial Permeability and Mucosal Eosinophilia in Ulcerative Colitis in Remission Compared With Irritable Bowel Syndrome and Health.

Authors:  Georgios Katinios; Maite Casado-Bedmar; Susanna A Walter; Maria Vicario; Ana M González-Castro; Olga Bednarska; Johan D Söderholm; Henrik Hjortswang; Åsa V Keita
Journal:  Inflamm Bowel Dis       Date:  2020-06-18       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.